Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China. Last year, Granules India had intimated about...
Alto Pharmacy raises funds from SoftBank
SoftBank’s second Vision Fund has led a new round of funding for Silicon Valley-based drug delivery firm Alto Pharmacy that valued it at over $1 billion, according to two people familiar with the development...
Japan drugstores plan mega-merger Oct 2021: Nikkei
Japanese drugstore company Matsumoto Kiyoshi Holdings and rival Cocokara Fine Inc plan to merge in October 2021, the Nikkei financial daily reported on Friday. The two companies announced last August that they were...
Cipla, PAG eye Wockhardt’s formulations business
Cipla and Asian buyout fund PAG are vying with each other to acquire a big chunk of Wockhardt’s domestic formulations business for Rs 2,100-2,800 crore ($300-400 million) as the indebted pharmaceutical company looks to...
AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys
U.S. drugmaker AbbVie’s (ABBV.N) $63 billion tie-up with Allergan (AGN.N) is getting help from Nestle (NESN.S) and AstraZeneca (AZN.L) buying up products the Irish-domiciled company is shedding to placate regulators...
Glenmark sells gynac business for Rs 115 crore
The sale of the gynac business comes two years after it sold its orthopedic business to the same company. Integrace will pay Rs 115 crore for four products of the portfolio that includes products like Dubagest, Mumfer...
HK-listed Sinopharm plans $524 million share sale to expand distribution network
China’s pharmaceutical products distributor Sinopharm Group Co Ltd said on Friday it plans to issue HK$4.07 billion ($523.66 million) worth of H shares to raise capital for the expansion of its distribution and retail...
Pfizer eyes share sale of Glaxo JV in 3-4 years
Pfizer Inc. is planning an initial public offering (IPO) of its consumer-health joint venture with GlaxoSmithKline Plc in three to four years as the two drugmakers turn back toward the lab. Pfizer chief executive...
Glenmark Pharma to raise up to $200 million to refinance debt
Glenmark Pharmaceuticals Ltd plans to raise up to $200 million through dollar-denominated bonds to refinance debt. The drugmaker will conduct investor road shows from 14 to 19 January across Asia, Europe and West Asia...
Spain’s Esteve to buy German pharma firm Riemser from Ardian
Spanish pharmaceuticals company Esteve has agreed to buy German peer Riemser from Ardian, the French buyout group said in a statement on Wednesday. Financial details of the transaction, which is expected to close in the...
True North to acquire 2.4% stake in Biocon Biologics
Home grown PE fund True North will invest about Rs.Rs 536 crore ($75 million) to acquire 2.4% stake in Biocon Biologics India Ltd, subsidiary of the Bengaluru based biopharmaceuticals Biocon Ltd. Biocon Board has...
Slayback Pharma raises fresh funds from PE firm Everstone Group
Everstone Group, a private equity and real estate investment firm that focuses on India and South-East Asia, on Monday said it has invested $50 million in the Series B funding of New Jersey-based Slayback Pharma Llc...
